Skip to main content
Retour
MCRPF logo

MicroPort Scientific Corporation

Qualité des données : 100%
Survendu
MCRPF
OTC Healthcare Medical - Devices
1,57 €
0,00 € (0,00%)
Cap. Boursière : 2,90B
Fourchette du Jour
1,57 € 1,57 €
Fourchette 52 Semaines
0,81 € 1,85 €
Volume
1 000
Moyenne 50J / 200J
1,45 € / 1,37 €
Clôture Précédente
1,57 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (631 pairs)

Métrique Action Médiane du Secteur
P/E -13,5 0,2
P/B 4,8 3,0
ROE % -31,6 3,6
Net Margin % -20,8 3,8
Rev Growth 5Y % 12,4 9,9
D/E 2,8 0,2

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 0,09 €
0,08 € – 0,09 €
1,43B 1
FY2026 0,05 €
0,05 € – 0,05 €
1,26B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2025-08-29 N/A -0,03 €
2025-03-28 N/A -0,06 €
2024-10-29 N/A -0,05 €
2024-03-28 N/A -0,17 €
2023-06-29 N/A -0,09 €
2022-12-30 N/A -0,13 €
2022-06-29 N/A -0,11 €
2021-12-31 N/A -0,10 €

Dividend History

3 yr streak

Yield

0,00%

Payout Ratio

0,00%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Jun 28, 2021 Aug 18, 2021 0,01 € 0,06%
Jun 22, 2020 Aug 17, 2020 0,01 € 0,21%
Jun 17, 2019 Aug 15, 2019 0,00 € 0,54%
May 16, 2018 Aug 15, 2018 0,00 € 0,23%
Jun 22, 2017 Aug 15, 2017 0,00 € 0,35%
Jun 28, 2013 0,08 € 9,30%
Jun 28, 2012 0,07 € 12,73%

Points Clés

Revenue grew 12,40% annually over 5 years — strong growth
Debt/Equity of 2,79 — high leverage
Negative free cash flow of -158,54M
PEG of 0,13 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,51%

Croissance

Revenue Growth (5Y)
12,40%
Revenue (1Y)8,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-31,58%
ROIC-4,13%
Net Margin-20,76%
Op. Margin-12,17%

Sécurité

Debt / Equity
2,79
Current Ratio1,47
Interest Coverage-1,18

Valorisation

P/E Ratio
-13,49
Forward P/E30,91
P/B Ratio4,81
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8,89% Revenue Growth (3Y) 10,96%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 12,40% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,04B Net Income (TTM) -214,92M
ROE -31,58% ROA -5,92%
Gross Margin 55,45% Operating Margin -12,17%
Net Margin -20,76% Free Cash Flow (TTM) -158,54M
ROIC -4,13% FCF Growth (3Y) N/A
Safety
Debt / Equity 2,79 Current Ratio 1,47
Interest Coverage -1,18
Dividends
Dividend Yield 0,00% Payout Ratio 0,00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 3 yrs
Valuation
P/E Ratio -13,49 Forward P/E 30,91
P/B Ratio 4,81 P/S Ratio 2,80
PEG Ratio 0,13 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 2,29 Fwd Earnings Yield 3,24%
FCF Yield -5,47%
Market Cap 2,90B Enterprise Value 3,87B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 1,04B 950,73M 840,83M 778,64M 648,73M
Net Income -214,92M -477,63M -436,52M -276,48M -191,25M
EPS (Diluted) -0,12 -0,27 -0,25 -0,16 -0,11
Gross Profit 574,09M 532,10M 501,77M 491,77M 436,03M
Operating Income -125,98M -516,17M -506,57M -293,62M -167,14M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3,63B 3,93B 3,99B 4,38B 2,47B
Total Liabilities 2,49B 2,53B 2,20B 2,16B 1,08B
Shareholders' Equity 603,22M 757,82M 1,14B 1,49B 1,13B
Total Debt 1,69B 1,70B 1,47B 1,24B 296,31M
Cash & Equivalents 713,00M 1,02B 1,20B 1,75B 1,00B
Current Assets 1,74B 2,01B 1,94B 2,39B 1,48B
Current Liabilities 1,18B 1,27B 662,13M 546,76M 519,38M